The efficacy of Shalaparni Churna in management of Generalized Anxiety Disorder in Adults

A Randomised Controlled Clinical Trial Of Medhya Effect Of Shalaparni (Desmodium gangeticum (L.) DC) Churna With Ashwagandha (Withania somnifera (L.) Dunal) Churna In Anavasthita Chitta In Perspective Of Generalized Anxiety Disorder in Adult Population. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/07/090769

Enrollment

Registered

2025-07-11

Start date

Unknown

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Participants will be selected irrespective of gender with age between 20-40 years, fulfilling criteria for generalized anxiety disorder given in the Diagnostic and Statistical Manual of Mental Disorders.

Exclusion criteria

Exclusion criteria: Participants with known case of any serious illness (cardiac, hepatic, renal disease, respiratory disorder, cancer etc.) Participants with known case of Mental retardation or having any other psychiatric treatment Pregnant or lactating woman

Design outcomes

Primary

Measure	Time frame
Decrease in the symptoms of anxiety and reduction of score (HAM-A Scale) by 50% or moreTimepoint: Every 15 days for 2 months	—

Secondary

Measure	Time frame
Evaluating any other effect of shalaparni clinicallyTimepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Asmita U Jadhav

Tilak Ayurved Mahavidyalaya, Pune

asmita.niramaya@gmail.com9359772607

Outcome results